Name: Xeris Biopharma Holdings, Inc. (XERS) Balance Sheet
Creator: FinSpry

Xeris Biopharma Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Xeris Biopharma Holdings, Inc. (XERS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	71.62	80.67	121.97	67.27	37.60
Short-Term Investments	0.00	5.00	0.00	35.16	96.19
Cash & Short-Term Investments	71.62	80.67	121.97	102.43	133.79
Accounts Receivable	40.42	30.23	30.83	17.46	6.88
Inventory	48.18	36.54	24.74	18.12	8.35
Other Current Assets	7.45	0.01	0.70	4.59	3.20
Total Current Assets	167.66	155.74	186.82	142.60	152.21
Non-Current Assets
Property, Plant & Equipment (Net)	28.21	30.18	3.99	6.63	6.71
Long-Term Investments	4.12	0.00	0.00	0.00	0.00
Goodwill	22.86	22.86	22.86	22.86	0.00
Intangible Assets	98.92	109.76	120.61	131.45	0.00
Other Non-Current Assets	5.41	4.81	4.73	0.83	0.23
Total Non-Current Assets	155.40	173.04	152.19	161.77	0.00
Total Assets	323.06	328.78	344.52	304.36	159.15
Current Liabilities
Accounts Payable	2.29	31.03	41.39	8.92	3.12
Short-Term Debt	15.10	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	15.10	0.00	0.00	0.00	0.00
Accrued Liabilities	56.80	45.66	44.09	51.17	21.07
Other Current Liabilities	20.17	18.36	2.66	18.95	4.02
Total Current Liabilities	100.44	51.32	73.62	79.04	28.21
Non-Current Liabilities
Long-Term Debt	217.01	223.05	196.48	88.07	87.02
Deferred Tax Liabilities	0.00	2.27	3.52	4.94	0.00
Other Non-Current Liabilities	1.97	37.92	53.71	37.08	10.16
Total Non-Current Liabilities	252.23	263.81	253.71	130.09	0.00
Total Liabilities	352.68	315.14	299.34	209.13	125.39
Stockholders' Equity
Common Stock	0.02	0.01	0.01	0.01	0.01
Retained Earnings	-671.86	-591.48	-554.80	-460.11	-337.39
Accumulated Other Comprehensive Income	-0.03	-0.03	-0.02	-0.03	0.01
Additional Paid-in Capital	642.26	610.25	599.97	555.36	0.00
Shares Outstanding	149.43	138.13	136.27	124.87	0.00
Total Stockholders' Equity	-29.62	13.69	45.16	95.23	33.76
Total Liabilities & Equity	323.06	322.60	344.52	304.36	0.00